D'Orazio & Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Buy
3,099
+24
+0.8% +$4.99K 0.09% 97
2026
Q1
$650K Buy
3,075
+4
+0.1% +$861 0.08% 91
2025
Q4
$631K Buy
3,071
+45
+1% +$8.47K 0.08% 97
2025
Q3
$475K Sell
3,026
-394
-12% -$60.9K 0.06% 118
2025
Q2
$575K Sell
3,420
-95
-3% -$14.1K 0.08% 96
2025
Q1
$484K Buy
3,515
+8
+0.2% +$1.02K 0.07% 98
2024
Q4
$415K Sell
3,507
-76
-2% -$8.87K 0.06% 107
2024
Q3
$396K Buy
3,583
+5
+0.1% +$523 0.06% 112
2024
Q2
$352K Sell
3,578
-133
-4% -$13.6K 0.05% 107
2024
Q1
$415K Buy
3,711
+15
+0.4% +$1.62K 0.07% 94
2023
Q4
$373K Buy
3,696
+399
+12% +$39.6K 0.07% 91
2023
Q3
$286K Buy
3,297
+373
+13% +$33.7K 0.06% 98
2023
Q2
$277K Buy
+2,924
New +$247K 0.06% 102
2021
Q4
Sell
-92
Closed -$5K 191
2021
Q3
$5K Buy
+92
New +$4.99K ﹤0.01% 628

Other funds holding CAH

D'Orazio & Associates's CAH Position: Q2 2026 in Review

D'Orazio & Associates increased its Cardinal Health (CAH) stake by 0.78% in Q2 2026, buying an estimated $4.99K and bringing the position to 3,099 shares worth $736K. The position accounts for 0.09% of the portfolio, ranked #97.

D'Orazio & Associates first reported a position in CAH in Q3 2021 and has held it in 14 quarters since. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • D'Orazio & Associates held 3,099 shares of Cardinal Health worth $736K as of Q2 2026.
  • D'Orazio & Associates bought 24 Cardinal Health shares in Q2 2026, an estimated $4.99K.
  • Cardinal Health made up 0.09% of D'Orazio & Associates's portfolio in Q2 2026, its #97 holding.
  • D'Orazio & Associates first reported a position in Cardinal Health in Q3 2021 and has held it in 14 quarters since.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on D'Orazio & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.